Little or no tumor specificity, poor tumor penetration, cancer cell heterogeneity, insufficient drug accumulation into the tumors abound with the development of multidrug resistance (MDR) conferred by many factors, and finally, undesirable side effects are all crucial matters that contribute to the lack of effectiveness and eventually therapeutic failure observed in conventional cancer therapeutics
doi:10.3390/ijms231710136 [Made by author on BioRender] These pathologies, on top of being associated with a degradation of how the Blood-Brain Barrier work, all involve altered processes in the brain implied in the development of the disease
Cancer Res 69:83568365 Shao N, Yuan L, Ma P, Zhou M, Xiao X, Cong Z, Wu Y, Xiao G, Fei J et al (2022) Heterochiral -peptide polymers combating multidrug-resistant cancers effectively without inducing drug resistance
Step 4: Add water to the peptide vial (the critical step) This is where technique matters most
The protocol is specifically designed around bedtime dosing to align the tesamorelin stimulus with your bodys natural nocturnal GH pulse